FKBP11 | OmnibusX

I. Expression across cell types

Name	Number of supported studies	Average coverage
natural killer cell	33 studies	30% ± 9%	Explore
plasma cell	27 studies	75% ± 22%	Explore
CD8-positive, alpha-beta T cell	25 studies	27% ± 10%	Explore
CD4-positive, alpha-beta T cell	18 studies	26% ± 5%	Explore
mucosal invariant T cell	16 studies	34% ± 13%	Explore
mature NK T cell	15 studies	30% ± 9%	Explore
T cell	14 studies	27% ± 8%	Explore
CD16-positive, CD56-dim natural killer cell, human	14 studies	35% ± 10%	Explore
gamma-delta T cell	13 studies	28% ± 7%	Explore
plasmablast	12 studies	71% ± 25%	Explore
fibroblast	12 studies	29% ± 13%	Explore
naive thymus-derived CD8-positive, alpha-beta T cell	11 studies	24% ± 6%	Explore
CD16-negative, CD56-bright natural killer cell, human	11 studies	28% ± 9%	Explore
CD8-positive, alpha-beta memory T cell	10 studies	31% ± 7%	Explore
CD4-positive, alpha-beta memory T cell	10 studies	24% ± 4%	Explore
IgG plasma cell	9 studies	67% ± 20%	Explore
effector memory CD8-positive, alpha-beta T cell	8 studies	27% ± 9%	Explore
IgA plasma cell	8 studies	70% ± 22%	Explore
effector CD8-positive, alpha-beta T cell	6 studies	26% ± 10%	Explore
naive thymus-derived CD4-positive, alpha-beta T cell	6 studies	20% ± 3%	Explore
effector memory CD4-positive, alpha-beta T cell	6 studies	26% ± 7%	Explore
epithelial cell	5 studies	38% ± 16%	Explore
innate lymphoid cell	5 studies	27% ± 9%	Explore
connective tissue cell	4 studies	35% ± 20%	Explore
goblet cell	4 studies	33% ± 10%	Explore
endothelial cell	4 studies	21% ± 3%	Explore
adventitial cell	4 studies	19% ± 3%	Explore
mesothelial cell	4 studies	27% ± 20%	Explore
effector CD4-positive, alpha-beta T cell	4 studies	34% ± 12%	Explore
CD4-positive helper T cell	4 studies	31% ± 9%	Explore
IgM plasma cell	4 studies	58% ± 14%	Explore
endothelial cell of vascular tree	4 studies	18% ± 3%	Explore
T-helper 17 cell	4 studies	35% ± 12%	Explore
plasmacytoid dendritic cell	4 studies	19% ± 4%	Explore
regulatory T cell	4 studies	21% ± 6%	Explore
pancreatic A cell	3 studies	28% ± 9%	Explore
intestinal crypt stem cell	3 studies	19% ± 1%	Explore
vein endothelial cell	3 studies	20% ± 2%	Explore
acinar cell	3 studies	51% ± 12%	Explore
pericyte	3 studies	22% ± 10%	Explore
T follicular helper cell	3 studies	27% ± 8%	Explore
group 3 innate lymphoid cell	3 studies	28% ± 3%	Explore
T-helper 1 cell	3 studies	31% ± 9%	Explore
megakaryocyte-erythroid progenitor cell	3 studies	32% ± 5%	Explore
effector memory CD8-positive, alpha-beta T cell, terminally differentiated	3 studies	27% ± 5%	Explore
central memory CD8-positive, alpha-beta T cell	3 studies	23% ± 5%	Explore

II. Expression across tissues

Name	Number of supported studies	Average coverage
peripheral blood	12 studies	20% ± 3%	Explore
intestine	5 studies	32% ± 15%	Explore
pancreas	4 studies	26% ± 7%	Explore
bone marrow	3 studies	31% ± 16%	Explore
liver	3 studies	21% ± 3%	Explore

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
lung	100%	1834.96	577 / 578	100%	20.61	1152 / 1155
stomach	100%	1598.37	358 / 359	100%	17.57	285 / 286
ovary	100%	989.73	180 / 180	99%	14.27	426 / 430
pancreas	100%	6770.04	328 / 328	99%	18.32	176 / 178
prostate	100%	1587.70	244 / 245	99%	28.96	498 / 502
breast	100%	1051.50	459 / 459	98%	14.46	1098 / 1118
liver	100%	2151.70	225 / 226	98%	22.80	398 / 406
uterus	100%	1136.14	170 / 170	97%	15.11	446 / 459
skin	96%	1483.47	1742 / 1809	99%	38.71	467 / 472
intestine	95%	1301.90	920 / 966	100%	19.08	525 / 527
bladder	95%	1280.52	20 / 21	96%	15.35	486 / 504
esophagus	94%	686.87	1356 / 1445	98%	12.98	179 / 183
adrenal gland	100%	1169.75	258 / 258	87%	11.92	199 / 230
kidney	99%	966.25	88 / 89	86%	9.64	771 / 901
thymus	100%	1319.35	652 / 653	80%	7.81	485 / 605
brain	75%	430.60	1987 / 2642	62%	4.47	440 / 705
lymph node	0%	0	0 / 0	100%	19.95	29 / 29
spleen	100%	4356.26	241 / 241	0%	0	0 / 0
tonsil	0%	0	0 / 0	100%	15.93	45 / 45
adipose	99%	1193.97	1197 / 1204	0%	0	0 / 0
eye	0%	0	0 / 0	96%	26.03	77 / 80
peripheral blood	96%	1548.86	893 / 929	0%	0	0 / 0
blood vessel	87%	719.31	1156 / 1335	0%	0	0 / 0
heart	67%	475.11	574 / 861	0%	0	0 / 0
muscle	5%	21.23	44 / 803	0%	0	0 / 0
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0
ureter	0%	0	0 / 0	0%	0	0 / 1

III. Associated gene sets

GO_0061077	Biological process	chaperone-mediated protein folding
GO_0005783	Cellular component	endoplasmic reticulum
GO_0016020	Cellular component	membrane
GO_0003755	Molecular function	peptidyl-prolyl cis-trans isomerase activity

IV. Literature review

[source]

Gene name	FKBP11
Protein name	FKBP prolyl isomerase 11 Peptidyl-prolyl cis-trans isomerase FKBP11 (PPIase FKBP11) (EC 5.2.1.8) (19 kDa FK506-binding protein) (19 kDa FKBP) (FKBP-19) (FK506-binding protein 11) (FKBP-11) (Rotamase) peptidylprolyl isomerase (EC 5.2.1.8)
Synonyms	hCG_1642966 FKBP19 UNQ336/PRO535
Description	FUNCTION: PPIases accelerate the folding of proteins during protein synthesis.
Accessions	E9PAR0 Q9NYL4 F8VU90 ENST00000552878.5 H0YHM7 Q86SR8 F8VXK0 ENST00000547789.1 J3KN11 ENST00000256680.10 ENST00000444214.6 ENST00000546847.5 ENST00000453172.2 [Q9NYL4-2] ENST00000550765.6 [Q9NYL4-1]

FKBP11 report

I. Expression across cell types

II. Expression across tissues

III. Associated gene sets

IV. Literature review